This is a synthetic peptide designed for use in combination with anti-TOLLIP antibody (Catalog #: ARP31758_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
TOLLIP
Reaktivität: Human, Affe
Wirt: Synthetic
BP
Applikationshinweise
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
TOLLIP
(Toll Interacting Protein (TOLLIP))
Hintergrund
TOLLIP is component of the signaling pathway of IL-1 and Toll-like receptors. It Inhibits cell activation by microbial products. It also recruits IRAK1 to the IL-1 receptor complex and inhibits IRAK1 phosphorylation and kinase activity.
Alias Symbols: FLJ33531, IL-1RAcPIP
Protein Interaction Partner: ATXN1,DAZAP2,IL1R1,IL1RAP,IRAK1,LDB1,RBPMS,RHOXF2,SEPT1,SETDB1,TLR2,TLR4,TOLLIP,TOM1,TOM1L1,XRN2,ZBTB16,ZHX1,DAZAP2,IL1R1,IL1RAP,IRAK1,LDB1,RBPMS,RHOXF2,SEPT1,SETDB1,TLR2,TLR4,TOLLIP,TOM1,XRN2,ZBTB16,ZHX1